Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal

Veracyte, a company whose tests help physicians make treatment decisions, is adding technology from NanoString to the fold to expand its diagnostic capabilities. South San Francisco-based Veracyte (NASDAQ: VCYT) announced Tuesday that it has reached a deal for global rights to develop and commercialize diagnostics based on the nCounter FLEX¬† system . The nCounter is […]

Click to view original post